Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Molecular Weight:
485.94
Purity:
>99.99%
CAS Number:
[267243-28-7]
Formula:
C24H25ClFN5O3
Target:
Virus Protease|||EGFR
T6136
* VAT and and shipping costs not included. Errors and price changes excepted
